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Abstract
Background: The process of rod photoreceptor genesis, cell fate determination and differentiation is complex and
multi-factorial. Previous studies have defined a model of photoreceptor differentiation that relies on intrinsic
changes within the presumptive photoreceptor cells as well as changes in surrounding tissue that are extrinsic to
the cell. We have used a proteomics approach to identify proteins that are dynamically expressed in the mouse
retina during rod genesis and differentiation.
Findings: A series of six developmental ages from E13 to P5 were used to define changes in retinal protein
expression during rod photoreceptor genesis and early differentiation. Retinal proteins were separated by
isoelectric focus point and molecular weight. Gels were analyzed for changes in protein spot intensity across
developmental time. Protein spots that peaked in expression at E17, P0 and P5 were picked from gels for
identification. There were 239 spots that were picked for identification based on their dynamic expression during
the developmental period of maximal rod photoreceptor genesis and differentiation. Of the 239 spots, 60 of them
were reliably identified and represented a single protein. Ten proteins were represented by multiple spots,
suggesting they were post-translationally modified. Of the 42 unique dynamically expressed proteins identified, 16
had been previously reported to be associated with the developing retina.
Conclusions: Our results represent the first proteomics study of the developing mouse retina that includes
prenatal development. We identified 26 dynamically expressed proteins in the developing mouse retina whose
expression had not been previously associated with retinal development.
Background
Retinal diseases involving degeneration of photorecep-
tors are an increasing cause of blindness in this country,
particularly among the aging population. Advances in
stem cell research may someday make replacement of
photoreceptors a feasible therapy for the treatment of
retinal degeneration. MacLearen and colleagues [1] pre-
viously reported that only post-mitotic rod precursors
were able to successfully and functionally integrate into
the mature retina. Currently we are not able to reliably
bias stem cells to adopt a photoreceptor fate. In this
regard, it will be crucial that we have a clear under-
standing of the retinal environment during normal
photoreceptor genesis as well as the combination of fac-
tors both intrinsic and extrinsic to developing retinal
cells that influence their decision to adopt a photorecep-
tor cell fate. To this end we have characterized the
developmental proteome of the mouse retina during late
embryonic and early postnatal development, the time
when the vast majority of rod photoreceptors are born,
commit to their cell fate and begin to differentiate.
We have used two-dimensional gel electrophoresis to
profile protein expression in developing mouse retinas.
Self-organizing mapping (SOM) was used to cluster pro-
tein spots into groups based on their changing levels of
expression across developmental time. From this we
identified clusters of dynamically expressed proteins that
peaked in expression at embryonic day 17 (E17; prior to
the peak of rod genesis); birth (P0; during the peak of
rod genesis) and postnatal day 5 (P5; a time when rods
are making irreversible cell fate commitment decisions
and have begun to differentiate). * Correspondence: mheather@iastate.edu
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Sample Preparation
Pups were taken from timed pregnant C57BL/6 mice at
ages E13, E15, E17, E18, P0 and P5. Eyes were enu-
cleated and retinas immediately placed in ice cold Phos-
phate Buffered Saline (PBS, 0.14 M NaCl, 2.68 mM KCl,
10.14 mM Na2HPO4, 1.76 mM KH2PO4, pH 7.2). The
tissue was suspended in rehydration buffer (8 M Urea,
2% CHAPS, 0.5% ZOOM Carrier Ampholytes (Invitro-
g e n ,C a r l s b a d ,C A ) ,0 . 0 0 2 %b r o m o p h e n o lb l u ea n d2 0
mM DTT), sonicated for 30 seconds and spun at 4,000
rpm for 10 minutes at 4°C. The pellet was re-suspended
in rehydration buffer (RHB). The sample was spun again
at 4,000 rpm for 10 minutes at 4°C. The remaining
supernatant was collected and frozen at -80°C. The total
protein concentration was determined using the EZQ
protein assay (Invitrogen). The sample was diluted to a
final concentration of 35 μg per 165 μl (0.212 μg/μl). All
experiments were conducted in accordance with the
ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research.
Two-dimensional separation of protein spots
Proteins were separated on the basis of their isoelectric
focus point (pI) using a ZOOM IPGRunner 7 cm strip
pH 3-10 (Invitrogen). The total protein loaded on the
strip was 35 μg. The first dimension running conditions
were as follows: 20 minutes at 200 V, 15 minutes at 450
V, 15 minutes at 750 V and 45 minutes at 2000 V. Pro-
teins were separated by molecular weight using a 7 cm
Bis Tris 3-12% pre-cast gel (Invitrogen). The gels were
subjected to a continuous voltage of 200 V for 50
minutes.
The gels were fixed with 50% Methanol, 10% Trichlor-
oacetic acid overnight, washed in ddH20f o l l o w e db ya
wash in 10% methanol, 7% acetic acid for 30 minutes.
The gels were stained with SYPRO Ruby (Invitrogen)
overnight and washed in 10% methanol, 7% acetic acid
for 60 minutes followed by dH20 the next morning.
They were imaged on a Typhoon 9410 fluorescent scan-
ner (GE Healthcare Life Sciences, Piscataway, NJ) for
quantitative analysis and then stained with Simply Blue
Coomassie (Invitrogen) overnight to allow hand picking
of spots.
Software Analysis
For the protein spot detection Phoretix 2D Expression
software (Nonlinear Dynamics; Nonlinear USA, Dur-
ham, NC) was used. Gels were warped and spots
matched automatically by the program but matching
was manually checked on all gels and adjusted to cor-
rect for incorrect matches. All gels were scrutinized to
ensure accurate spot detection and matching, and that
artifacts were not counted as actual spots. Three repli-
cates of each age were grouped together to make an
average gel for that age. Spots present on at least two of
the three gels were included on the average gel for that
age group. Expression values for each spot were
expressed as protein spot volumes. Background subtrac-
tion was employed using the Mode of Non-Spot
(default) at a margin of 45 (default). The spot volume
was normalized to total spot volume on its average gel.
Clustering of Data
To cluster the data, we used the SOM (Self-Organizing
Maps) method provided by the GeneCluster 2.0 [2].
Available at http://www.broad.mit.edu/cancer/software/
genecluster2/gc2.html. To preprocess the data, we
replaced missing expression values with 0s, interpreting
a missing expression value as an absence of a signal,
and normalized the data to mean of 0 and variance of 1.
The SOM algorithm was executed with the desired clus-
ter range of 6 and the rest of the parameters left
unchanged (50000 iterations, seed range of 42, initializa-
tion of centroids to random vectors, bubble neighbor-
hood, initial and final learning weights of .1 and .005,
and initial and final sigmas determining the size of the
update neighborhood of a centroid set to 5 and .5,
respectively). This produced 6 clusters with the peak at
each time point.
Spot Picking and Identification of Proteins
For protein identification, gels were stained with Simply-
Blue (Invitrogen). Spots of interest were hand picked
based on clustering results and maps from Phoretix soft-
ware analysis. Trypsin digestion and deposition to a tar-
get for MALDI were performed using an Ettan Spot
Handling Workstation (Amersham Biosciences, Newark,
NJ, USA). For MALDI analysis, the tryptic peptides dis-
solved in 50% CH3CN/0.1% TFA were mixed with a
matrix solution (CHCA 10 mg/mL in 50% CH3CN/0.1%
TFA) and applied on a target plate. For ESI experiments,
protein digest solution was taken out after trypsin diges-
tion, extracted and dried to needed volume.
MALDI-TOF MS/MS analyses were performed using a
QSTAR XL quadrupole TOF mass spectrometer (AB/
MDS Sciex, Toronto, Canada) equipped with an MALDI
ion source. The mass spectrometer was operated in the
positive ion mode. Mass spectra for MS analysis were
acquired over m/z 500 to 4000. After every regular MS
acquisition, MS/MS acquisition was performed against
most intensive ions. The molecular ions were selected
by information dependent acquiring in the quadrupole
analyzer and fragmented in the collision cell. For ESI
Mass Spectrometry the peptide digest samples were
introduced to the QSTAR XL quadrupole TOF mass
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autosampler (LC Packings, San Francisco, USA). Other
parameters of the mass spectrometer were the same as
MALDI analysis.
All spectra were processed by MASCOT
(MatrixScience, London, UK) database search. Peak lists
were generated by Analyst QS (AB/MDS Sciex, Toronto,
Canada) and were used for MS/MS ion searches. Typical
search parameters were as follows: Max missing cleavage
is one, fixed modification carboxyamidomethyl cysteine,
variable modification oxidation of methionine. Peptide
mass tolerances were +/- 100 ppm. Fragment mass tol-
erances were +/- 1 Da. No restrictions on protein mole-
cular weight were applied. Protein identification was
based on the probability based Mowse Score. The signif-
icance threshold p was set to less than 0.05.
Results and Discussion
As an initial step to better understand rod photoreceptor
development we profiled the proteome of the developing
mouse retina during the time of maximal rod photore-
ceptor genesis and cell fate determination. To make the
expression analysis more robust, we analyzed retinas
from ages embryonic day (E)13, E15, E17 E18 P0 and P5.
Representative gels from each age are shown in Figure 1.
Expression values for each protein spot were used to
cluster spots based on their changing levels of expression
from E13 to P5. Figure 2 shows the SOM clustering
results when 6 clusters were pre-specified. The resulting
clusters contained groups of proteins that had their peak
in expression at each of the ages examined. For this ana-
lysis, we were most interested in the clusters that con-
tained proteins that peaked at E17, which is just prior to
the peak of rod photoreceptor genesis, P0 which is at the
peak of rod photoreceptor genesis and P5, which is past
the time of rod genesis, but the time when early, irrever-
sible rod differentiation is occurring.
Based on the clustering analysis, spots in cluster 1 (c1;
expression peaked at E17), c4 (expression peaked at P0)
and c0 (expression peaked at P5) were hand-picked for
identification. Of the spots that were picked for analysis,
71.1% (170/239) returned high probability IDs that
could be confirmed based on known or predicted mole-
cular weights and isoelectric focus points (pIs). How-
ever, some spots returned two different identities, likely
because the spots contained both proteins. These spots
were not considered further. The resulting dataset, then,
included 60 spots, that represented 42 unique proteins.
Tables 1, 2 and 3 list the protein spots whose expression
peaked at E17, P1 and P5 respectively.
To better understand the proteins that were identified
in this analysis, we did a manual literature search to look
Figure 1 Representative images of gels from embryonic and postnatal retinal protein samples. Proteins were separated first by isoelectric
focus point (pH 3-10) then by molecular weight (kDa).
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Page 3 of 8Figure 2 Changes in protein expression across developmental time were used to cluster protein spots into six groups (c0-c5).E a c h
group contained protein spots whose expression peaked at a particular developmental age. In each panel the y-axis represents relative
expression levels and the x-axis represents the ages analyzed. Black dots represent ages E13, E15, E17, E18, P0 and P5 from left to right
respectively. Protein spots whose expression peaked at E17 (c1), P0 (c4) and P5 (c0) were picked for identification. Gray lines represent one
standard deviation on either side of the mean expression pattern for each group of proteins.
Table 1 Dynamically expressed retinal proteins that peaked at E17.
Primary Accession
number (UniProt/
SwissProt)
Protein Molecular
Weight**
(Daltons)
MOWSE
Score(s)***
Spot
Number(s)
Retinal
Development
Brain
Development
Q8CAY6 Acetyl-CoA acetyltransferase, cytosolic (EC
2.3.1.9)
41298 80 4849 [8]
Q04447* Creatine kinase B-type (EC 2.7.3.2) 42713 34 4848 [9]
Q8VCG1 Dutp protein 21251 34 4876
P63017* Heat shock cognate 71 kDa protein 70871 107 4546
O35737 Heterogeneous nuclear ribonucleoprotein H 49199 37 4918
Q9D6R2 Isocitrate dehydrogenase [NAD] subunit
alpha, mitochondrial precursor (EC 1.1.1.41)
39639 67 4614
P08249 Malate dehydrogenase, mitochondrial
precursor (EC 1.1.1.37)
35611 24 4693 [12]
Q9DBJ1* Phosphoglycerate mutase 1 (EC 5.4.2.1) 28832 32 4979
P17918 Proliferating cell nuclear antigen
(PCNA) (Cyclin)
28785 54 4624
Q9QUM9 Proteasome subunit alpha type 6
(EC 3.4.25.1)
27372 23 4976
P09103 Protein disulfide-isomerase precursor
(EC 5.3.4.1)
57144 142 4775 [13]
P62492 Ras-related protein Rab-11A 24262 37 4638 [14] [14]
Q8K2T1 RIKEN cDNA 1110025F24 34376 39 4694
P54227* Stathmin (Phosphoprotein p19) 17274 66, 112 4879, 24716 [8,9,15,16]
P68369* Tubulin alpha-1 chain 50136 42 4589 [17]
P68372 Tubulin beta-2c chain 49831 55 4914
*Protein that was represented on a gel by more than one spot.
**Theoretical molecular weights from UniProt database.
***Probability-based MOSE score. Significance threshold less than 0.05.
Numbers indicate references used to link the protein to search criteria.
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Primary Accession
number (UniProt/
SwissProt)
Protein Molecular
Weight**
(Daltons)
MOWSE
Score(s)***
Spot
Number(s)
Retinal
Development
Brain
Development
P60710 Actin, cytoplasmic 1 (Beta-actin) 41737 125 4916 [18]
P17182* Alpha enolase (EC 4.2.1.11) 47141 51 24721 [9]
Q8VHX2 Ectodysplasin A receptor associated
adapter protein
23753 22 4629
Q9DBJ1* Phosphoglycerate mutase 1 (EC 5.4.2.1) 28832 32 4732
P54227* Stathmin (Phosphoprotein p19) 17274 55, 62 4643, 4937 [9,15]
P17751 Triosephosphate isomerase (EC 5.3.1.1) 26713 50 4733
*Protein that was represented on a gel by more than one spot.
**Theoretical molecular weights from UniProt database.
***Probability-based MOSE score. Significance threshold less than 0.05.
Numbers indicate references used to link the protein to search criteria.
Table 3 Dynamically expressed retinal proteins that peaked at P5.
Primary Accession
number (UniProt/
SwissProt)
Protein Name Molecular
Weight**
(Daltons)
MOWSE
Score(s)
***
Spot
Number
(s)
Retinal
Development
Brain
Development
P62259 14-3-3 protein epsilon 29174 61 4741 [19] [20]
P14206 40S ribosomal protein SA 40894-44505 51 4851
Q3U0V1 Far upstream element binding protein-1 76810 69 4532 [8]
P17182* Alpha-enolase (EC 4.2.1.11) 47141 44 4990 [8,9]
P62996 Arginine/serine-rich splicing factor 10 33666 31 4852
Q04447* Creatine kinase B-type (EC 2.7.3.2) 42713 30, 34 4747, 4771 [8,9]
P08113* Endoplasmin precursor 92476 32, 34, 41 4516,
4520, 4529
Q8BGD9 Eukaryotic translation initiation factor 4B (eIF-4B) 68840 52 4549 [21]
P51880 Fatty acid-binding protein, brain (B-FABP) 14893 137 4743 [9,22-24] [22-24]
Q05816 Fatty acid-binding protein, epidermal 15137 25 4939 [25] [26]
P63017* Heat shock cognate 71 kDa protein 70871 69, 236,
103, 107
4661,
4896,
4553, 4835
P07901 Heat shock protein HSP 90-alpha 84657 31 4658
Q8BG05* Heterogeneous nuclear ribonucleoprotein A3 39652 59 4690 [8]
P61979 Heterogeneous nuclear ribonucleoprotein K 50970 34 4674 [8,27]
P10853* Histone H2B F 13936 39, 25 4958, 4953 [28]
Q60605 Myosin light polypeptide 6 16779 66 4952 [29]
Q62433 NDRG1 protein (N-myc downstream regulated
gene 1 protein)
43009 74 4919 [8] [30]
Q99LD8 NG, NG- dimethylarginine dimethyl-
aminohydrolase 2 (EC 3.5.3.18)
29646 176 4768
P28656* Nucleosome assembly protein 1-like 1 45345 44, 54 4717, 5045
Q9JJU8 SH3 domain-binding glutamic acid-rich-like
protein
12811 43 24724
Q64674 Spermidine synthase (EC 2.5.1.16) 33995 30 24715
Q8BL97 Splicing factor, arginine/serine-rich 7 32316 31 4620
P68369* Tubulin alpha-1 chain (Alpha-tubulin 1) 50136 40, 53 4789,
24719
[17]
P99024* Tubulin beta-5 chain 496671 57, 108 5043, 5044
Q9DBP5 UMP-CMP kinase (EC 2.7.4.14) 22165 75 4631
*Protein that was represented on a gel by more than one spot.
**Theoretical molecular weights from UniProt database.
***Probability-based MOSE score. Significance threshold less than 0.05.
Numbers indicate references used to link the protein to search criteria.
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Page 5 of 8for published links between each protein and normal ret-
inal development and brain development. Of 60 protein
spots whose expression peaked at E17, 16 were identified.
Based on a search of the literature, 5 proteins that peaked
at E17 had been previously linked to retinal development
and 3 to brain development (Table 1 and Figure 3). Of 56
protein spots whose expression peaked at P0, 7 were
identified. Based on a search of the literature, 2 proteins
had been previously linked to retinal development and 1
to brain development (Table 2 and Figure 4). Of 123 pro-
tein spots whose expression peaked at P5, 36 were identi-
fied. Based on a search of the literature, 12 had been
previously linked to retinal development and 5 to brain
development (Table 3 and Figure 5).
This analysis identified 42 distinct proteins that are
dynamically expressed in the retina during rod photore-
ceptor development. Of these proteins, 10 were repre-
sented by more than one protein spot, suggesting they
are dynamically post-translationally modified. Finally, a
manual search of the published literature identified
prior published reports had already linked 16 of the 42
proteins to retinal development in some way.
The proteins reported here most certainly do not con-
stitute a complete list of molecules dynamically
expressed during development. A number of proteins
already demonstrated to be important during photore-
ceptor development do not appear in our dataset. This
could be due to a number of factors including the rela-
tive abundance of a protein in the samples, relative
change in it’s expression levels, high-confidence identifi-
cation of the protein with MALDI MS/MS, verification
of the protein spot ID based on 2D gel position and the
protein spot containing a single protein. Thus, while
this study reports important results on it’s own, we also
consider it complimentary to other reports of gene or
protein expression in the developing mouse retina.
A number of important studies have used expression
analysis to identify genes or proteins expressed in the
developing mouse retina [3-8]. The motivation behind
this approach is two-fold. Firstly, molecules important for
particular events during retinal development may be
expected to change at the time that said event is occur-
ring. Secondly, profiling genes that change in relation to
one another may help investigators to identify pathways
or groups of genes that work together during retinal
development. Protein expression profiling can be a
powerful compliment to mRNA expression analysis.
Changes in protein expression are a more definitive
Figure 3 Proteins whose expression peaked at E17.P r o t e i n
spots, on a representative 2D gel from an E17 mouse retina protein
sample are labeled by spot numbers given in table 1.
Figure 5 Proteins whose expression peaked at P5. Protein spots,
on a representative 2D gel from a P5 mouse retina protein sample
are labeled by spot numbers given in table 3.
Figure 4 Proteins whose expression peaked at P0. Protein spots,
on a representative 2D gel from a P0 mouse retina protein sample
are labeled by spot numbers given in table 2.
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H o w e v e r ,t h em o s tp o w e r f u lc o m p l i m e n tt h a t2 Dg e l
expression analysis offers is the ability to capture not only
changes in expression but also changes in post-transla-
tional modification. The existence of post-translational
modifications can be discovered by differences in pI or
molecular weight. In our analysis alone, we identified 10
proteins likely with dynamic post-translational modifica-
tions. In future experiments specific dyes for phosphory-
l a t i o na n dg l y c o s y l a t i o nm a yb eu s e f u lt oi d e n t i f ya n d
quantify specific post-translational modifications.
A previously published complementary study used 2D-
gel electrophoresis to profile dynamic changes in protein
expression in the postnatal mouse retina [8]. In this
study they identified 174 total protein spots. Of the 170
total protein spots that returned identities in the current
analysis (E17, P0 and P5), 47 of them were in common
with the previous study. Protein expression profiling has
also been successfully applied in the developing chick
retina [9-11]. Even though these studies may have pro-
filed different ages and/or species it still may be useful to
integrate the information from these and other studies to
generate a more comprehensive profile of changes in
protein expression during vertebrate retinal development.
We have used protein expression profiling to identify
retinal proteins with dynamic changes in expression
during rod photoreceptor genesis. We identified 16 pro-
teins that have been previously associated with the
developing retina and 26 that have not been previously
associated with retinal development.
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